Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAS-106 in Platinum-Refractory Head and Neck Cancer
NCT00737360Phase 2Terminated
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Aug 2008
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of ethynylcytidine in head and neck cancer (HNC), nasopharyngeal carcinoma (NPC), sponsored by Taiho Pharmaceutical Co., Ltd.. Started Aug 2008; status: terminated.
02
Drugs
ethynylcytidine
03
Conditions
head and neck cancer (HNC)nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT00737360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00737360.